☰

Brian J. North, Ph.D. - Publications

Affiliations: 
2005 University of California, San Francisco, San Francisco, CA 
Area:
Neuroscience
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

33 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Shimizu K, Gi M, Suzuki S, North BJ, Watahiki A, Fukumoto S, Asara JM, Tokunaga F, Wei W, Inuzuka H. Interplay between protein acetylation and ubiquitination controls MCL1 protein stability. Cell Reports. 37: 109988. PMID 34758305 DOI: 10.1016/j.celrep.2021.109988  0.356
2019 Cheng J, Guo J, North BJ, Wang B, Cui CP, Li H, Tao K, Zhang L, Wei W. Functional analysis of deubiquitylating enzymes in tumorigenesis and development. Biochimica Et Biophysica Acta. Reviews On Cancer. 188312. PMID 31449841 DOI: 10.1016/J.Bbcan.2019.188312  0.406
2018 Cheng J, Guo J, North BJ, Tao K, Zhou P, Wei W. The emerging role for Cullin 4 family of E3 ligases in tumorigenesis. Biochimica Et Biophysica Acta. Reviews On Cancer. PMID 30602127 DOI: 10.1016/J.Bbcan.2018.11.007  0.33
2018 Ma Y, Cui D, Xiong X, Inuzuka H, Wei W, Sun Y, North BJ, Zhao Y. SCFβ-TrCP ubiquitinates CHK1 in an AMPK-dependent manner in response to glucose deprivation. Molecular Oncology. PMID 30428154 DOI: 10.1002/1878-0261.12403  0.326
2018 Ci Y, Li X, Chen M, Zhong J, North BJ, Inuzuka H, He X, Li Y, Guo J, Dai X. SCFE3 ubiquitin ligase targets the tumor suppressor ZNRF3 for ubiquitination and degradation. Protein & Cell. PMID 29497989 DOI: 10.1007/S13238-018-0510-2  0.335
2017 Cheng J, Guo J, Wang Z, North BJ, Tao K, Dai X, Wei W. Functional analysis of Cullin 3 E3 ligases in tumorigenesis. Biochimica Et Biophysica Acta. PMID 29128526 DOI: 10.1016/J.Bbcan.2017.11.001  0.403
2017 Tan Y, Ci Y, Dai X, Wu F, Guo J, Liu D, North BJ, Huo J, Zhang J. Cullin 3SPOP ubiquitin E3 ligase promotes the poly-ubiquitination and degradation of HDAC6. Oncotarget. PMID 28599312 DOI: 10.18632/Oncotarget.18141  0.446
2017 Wang B, Jie Z, Joo D, Ordureau A, Liu P, Gan W, Guo J, Zhang J, North BJ, Dai X, Cheng X, Bian X, Zhang L, Harper JW, Sun SC, et al. TRAF2 and OTUD7B govern a ubiquitin-dependent switch that regulates mTORC2 signalling. Nature. PMID 28489822 DOI: 10.1038/Nature22344  0.382
2017 North BJ, Almeciga-Pinto I, Tamang D, Yang M, Jones SS, Quayle SN. Enhancement of pomalidomide anti-tumor response with ACY-241, a selective HDAC6 inhibitor. Plos One. 12: e0173507. PMID 28264055 DOI: 10.1371/Journal.Pone.0173507  0.34
2017 Nihira NT, Ogura K, Shimizu K, North BJ, Zhang J, Gao D, Inuzuka H, Wei W. Acetylation-dependent regulation of MDM2 E3 ligase activity dictates its oncogenic function. Science Signaling. 10. PMID 28196907 DOI: 10.1126/Scisignal.Aai8026  0.381
2017 Shimizu K, Fukushima H, Ogura K, Lien EC, Nihira NT, Zhang J, North BJ, Guo A, Nagashima K, Nakagawa T, Hoshikawa S, Watahiki A, Okabe K, Yamada A, Toker A, et al. The SCFβ-TRCP E3 ubiquitin ligase complex targets Lipin1 for ubiquitination and degradation to promote hepatic lipogenesis. Science Signaling. 10. PMID 28049764 DOI: 10.1126/Scisignal.Aah4117  0.318
2016 Li X, Dai X, Wan L, Inuzuka H, Sun L, North BJ. Smurf1 regulation of DAB2IP controls cell proliferation and migration. Oncotarget. PMID 27036023 DOI: 10.18632/Oncotarget.8424  0.437
2015 Rumpf T, Schiedel M, Karaman B, Roessler C, North BJ, Lehotzky A, Oláh J, Ladwein KI, Schmidtkunz K, Gajer M, Pannek M, Steegborn C, Sinclair DA, Gerhardt S, Ovádi J, et al. Selective Sirt2 inhibition by ligand-induced rearrangement of the active site. Nature Communications. 6: 6263. PMID 25672491 DOI: 10.1038/Ncomms7263  0.34
2014 Wu X, Fukushima H, North BJ, Nagaoka Y, Nagashima K, Deng F, Okabe K, Inuzuka H, Wei W. SCFβ-TRCP regulates osteoclastogenesis via promoting CYLD ubiquitination. Oncotarget. 5: 4211-21. PMID 24961988 DOI: 10.18632/Oncotarget.1971  0.379
2014 Dai X, North BJ, Inuzuka H. Negative regulation of DAB2IP by Akt and SCFFbw7 pathways. Oncotarget. 5: 3307-15. PMID 24912918 DOI: 10.18632/Oncotarget.1939  0.42
2012 Bonezzi K, Belotti D, North BJ, Ghilardi C, Borsotti P, Resovi A, Ubezio P, Riva A, Giavazzi R, Verdin E, Taraboletti G. Inhibition of SIRT2 potentiates the anti-motility activity of taxanes: implications for antineoplastic combination therapies. Neoplasia (New York, N.Y.). 14: 846-54. PMID 23019416 DOI: 10.1593/Neo.12728  0.552
2012 Price NL, Gomes AP, Ling AJ, Duarte FV, Martin-Montalvo A, North BJ, Agarwal B, Ye L, Ramadori G, Teodoro JS, Hubbard BP, Varela AT, Davis JG, Varamini B, Hafner A, et al. SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function. Cell Metabolism. 15: 675-90. PMID 22560220 DOI: 10.1016/J.Cmet.2012.04.003  0.333
2011 Beirowski B, Gustin J, Armour SM, Yamamoto H, Viader A, North BJ, Michán S, Baloh RH, Golden JP, Schmidt RE, Sinclair DA, Auwerx J, Milbrandt J. Sir-two-homolog 2 (Sirt2) modulates peripheral myelination through polarity protein Par-3/atypical protein kinase C (aPKC) signaling. Proceedings of the National Academy of Sciences of the United States of America. 108: E952-61. PMID 21949390 DOI: 10.1073/Pnas.1104969108  0.31
2008 Bonezzi K, North B, Manzotti C, Riva A, Verdin E, Giavazzi R, Taraboletti G. 452 POSTER Tubulin acetylation and the antimotility effects of tubulin-targeting agents European Journal of Cancer Supplements. 6: 142. DOI: 10.1016/S1359-6349(08)72386-3  0.408
2007 North BJ, Verdin E. Interphase nucleo-cytoplasmic shuttling and localization of SIRT2 during mitosis. Plos One. 2: e784. PMID 17726514 DOI: 10.1371/Journal.Pone.0000784  0.577
2007 Ahuja N, Schwer B, Carobbio S, Waltregny D, North BJ, Castronovo V, Maechler P, Verdin E. Regulation of insulin secretion by SIRT4, a mitochondrial ADP-ribosyltransferase. The Journal of Biological Chemistry. 282: 33583-92. PMID 17715127 DOI: 10.1074/Jbc.M705488200  0.647
2007 North BJ, Verdin E. Mitotic regulation of SIRT2 by cyclin-dependent kinase 1-dependent phosphorylation. The Journal of Biological Chemistry. 282: 19546-55. PMID 17488717 DOI: 10.1074/Jbc.M702990200  0.562
2007 North BJ, Sinclair DA. Sirtuins: a conserved key unlocking AceCS activity. Trends in Biochemical Sciences. 32: 1-4. PMID 17141505 DOI: 10.1016/J.Tibs.2006.11.002  0.402
2005 North BJ, Schwer B, Ahuja N, Marshall B, Verdin E. Preparation of enzymatically active recombinant class III protein deacetylases. Methods (San Diego, Calif.). 36: 338-45. PMID 16091304 DOI: 10.1016/J.Ymeth.2005.03.004  0.674
2005 Waltregny D, Glénisson W, Tran SL, North BJ, Verdin E, Colige A, Castronovo V. Histone deacetylase HDAC8 associates with smooth muscle alpha-actin and is essential for smooth muscle cell contractility. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 19: 966-8. PMID 15772115 DOI: 10.1096/Fj.04-2303Fje  0.544
2005 Pagans S, Pedal A, North BJ, Kaehlcke K, Marshall BL, Dorr A, Hetzer-Egger C, Henklein P, Frye R, McBurney MW, Hruby H, Jung M, Verdin E, Ott M. SIRT1 regulates HIV transcription via Tat deacetylation. Plos Biology. 3: e41. PMID 15719057 DOI: 10.1371/Journal.Pbio.0030041  0.532
2004 Waltregny D, North B, Van Mellaert F, De Leval J, Verdin E, Castronovo V. Screening of histone deacetylases (HDAC) expression in human prostate cancer reveals distinct class I HDAC profiles between epithelial and stromal cells European Journal of Histochemistry. 48: 273-290. PMID 15590418 DOI: 10.4081/897  0.556
2004 Waltregny D, De Leval L, Glénisson W, Ly Tran S, North BJ, Bellahcène A, Weidle U, Verdin E, Castronovo V. Expression of histone deacetylase 8, a class I histone deacetylase, is restricted to cells showing smooth muscle differentiation in normal human tissues. The American Journal of Pathology. 165: 553-64. PMID 15277229 DOI: 10.1016/S0002-9440(10)63320-2  0.581
2004 North BJ, Verdin E. Sirtuins: Sir2-related NAD-dependent protein deacetylases. Genome Biology. 5: 224. PMID 15128440 DOI: 10.1186/Gb-2004-5-5-224  0.577
2004 Verdin E, Dequiedt F, Fischle W, Frye R, Marshall B, North B. Measurement of Mammalian Histone Deacetylase Activity Methods in Enzymology. 377: 180-196. PMID 14979025 DOI: 10.1016/S0076-6879(03)77010-4  0.552
2003 North BJ, Marshall BL, Borra MT, Denu JM, Verdin E. The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase. Molecular Cell. 11: 437-44. PMID 12620231 DOI: 10.1016/S1097-2765(03)00038-8  0.604
2002 Verzi MP, Anderson JP, Dodou E, Kelly KK, Greene SB, North BJ, Cripps RM, Black BL. N-twist, an evolutionarily conserved bHLH protein expressed in the developing CNS, functions as a transcriptional inhibitor. Developmental Biology. 249: 174-90. PMID 12217327 DOI: 10.1006/Dbio.2002.0753  0.338
2002 Schwer B, North BJ, Frye RA, Ott M, Verdin E. The human silent information regulator (Sir)2 homologue hSIRT3 is a mitochondrial nicotinamide adenine dinucleotide-dependent deacetylase. The Journal of Cell Biology. 158: 647-57. PMID 12186850 DOI: 10.1083/Jcb.200205057  0.664
Show low-probability matches.